166-180 of 893

A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
The Drug ReportA Guide for Off-Label Use of Treatments for COVID-19 from the ASHP

REMS-Required Drug Monitoring During the COVID-19 Pandemic
The Drug ReportREMS-Required Drug Monitoring During the COVID-19 Pandemic

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19
The Drug ReportRenin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19

CDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19
The Drug ReportCDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19

Amesh Adalja, Infectious Disease Expert, Answers Your Latest COVID-19 Questions
Public Health On CallAmesh Adalja, Infectious Disease Expert, Answers Your Latest COVID-19 Questions
- advertisement

Baltimore’s Grassroots Effort to Provide Mental Health Support to City Residents in COVID-19
Public Health On CallBaltimore’s Grassroots Effort to Provide Mental Health Support to City Residents in COVID-19

Former CDC Director Tom Frieden on What We Need to Do Now & Next to Reopen
Public Health On CallFormer CDC Director Tom Frieden on What We Need to Do Now & Next to Reopen

A Nurse’s Perspective on Testing Capacity & Mask Recommendations
Public Health On CallA Nurse’s Perspective on Testing Capacity & Mask Recommendations

What the US Can Learn from Singapore’s COVID-19 Response
Public Health On CallWhat the US Can Learn from Singapore’s COVID-19 Response
- advertisement

An Oncologist’s Perspective from Seattle, Epicenter of America’s First COVID-19 Outbreak
COVID-19: On The FrontlinesAn Oncologist’s Perspective from Seattle, Epicenter of America’s First COVID-19 Outbreak

Lessons from Liberia: What the US Can Learn from the 2014 Ebola Outbreak
Public Health On CallLessons from Liberia: What the US Can Learn from the 2014 Ebola Outbreak









































